This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1. H Feldmann , M Czub , S Jones , et alEmerging and re-emerging infectious diseases. Med Microbiol Immunol. 2002;191:63–74.
2. DL Heymann , GR. Rodier Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases. Lancet Infect Dis. 2001;1 (5):345–353.
5. ME. Wilson Travel and the emergence of infectious diseases. Emerg Infect Dis. 1995;1:39–46.
6. DL Heymann , GR. Rodier Global surveillance of communicable diseases. Emerg Infect Dis. 1998;4:362–365.
7. JP. Woodall Global surveillance of emerging diseases: the ProMED-mail perspective. Cad Saude Publica. 2001;17 (Suppl):147–154.
8. LO. Gostin International infectious disease law: revision of the World Health Organization’s International Health Regulations. JAMA. 2004;291:2623–2627.
10.How is WHO responding to global public health threats? PLoS Med. 2007;4:e197.
11. MG Baker , DP. Fidler Global public health surveillance under new international health regulations. Emerg Infect Dis. 2006;12:1058–1065.
12. LO Gostin , R Bayer , AL. Fairchild Ethical and legal challenges posed by severe acute respiratory syndrome: implications for the control of severe infectious disease threats. JAMA. 2003;290:3229–3237.
16. LO. Gostin Pandemic influenza: public health preparedness for the next global health emergency. J Law Med Ethics. 2004;32:565–573.
17. JS Gear , GA Cassel , AJ Gear , et alOutbreake of Marburg virus disease in Johannesburg. BMJ. 1975;4:489–493.
20. T Ramamurthy , S Garg , R Sharma , et alEmergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet. 1993;341:703–704.
21. PM Sharp , E Bailes , RR Chaudhuri , CM Rodenburg , MO Santiago , BH. Hahn The origins of acquired immune deficiency syndrome viruses: where and when? Philos Trans R Soc Lond B Biol Sci. 2001;356:867–876.
22. KD Mandl , JM Overhage , MM Wagner , et alImplementing syndromic surveillance: a practical guide informed by the early experience. J Am Med Inform Assoc. 2004;11:141–150.
24. M Van Herp , V Parque , E Rackley , N. Ford Mortality, violence and lack of access to healthcare in the Democratic Republic of Congo. Disasters. 2003;27:141–153.
25. PB. Spiegel HIV behavioural surveillance surveys in conflict and post-conflict situations: A call for improvement. Global Public Health. 2006;1:147–156.
29. J. Woodall Official versus unofficial outbreak reporting through the Internet. Int J Med Inform. 1997;47:31–34.
30. DL Heymann , G. Rodier Global surveillance, national surveillance, and SARS. Emerg Infect Dis. 2004;10:173–175.
32. TW Grein , KB Kamara , G Rodier , et alRumors of disease in the global village: outbreak verification. Emerg Infect Dis. 2000;6:97–102.
33. NM M’Ikanatha , DD Rohn , C Robertson , et alUse of the internet to enhance infectious disease surveillance and outbreak investigation. Biosecur Bioterror. 2006;4:293–300.
35. M. Hugh-Jones Global awareness of disease outbreaks: the experience of ProMED-mail. Public Health Rep. 2001;116 (Suppl 2):27–31.
36. J Woodall , CH. Calisher ProMED-mail: background and purpose. Emerg Infect Dis. 2001;7 (3):563.
37. LC Madoff , JP. Woodall The internet and the global monitoring of emerging diseases: lessons from the first 10 years of ProMED-mail. Arch Med Res. 2005;36:724–730.
40. M. Larkin Technology and public health: Healthmap tracks global diseases. Lancet Infect Dis. 2007;7:91.
44. M Brodie , RE Flournoy , DE Altman , RJ Blendon , JM Benson , MD. Rosenbaum Health information, the Internet, and the digital divide. Health Aff (Millwood). 2000;19:255–265.
46. I Arita , M Nakane , K Kojima , N Yoshihara , T Nakano , A. El-Gohary Role of a sentinel surveillance system in the context of global surveillance of infectious diseases. Lancet Infect Dis. 2004;4:171–177.
47. PJ Guerin , RF Grais , JA Rottingen , AJ. Valleron Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources. BMC Public Health. 2007;7:8.
48. BR. Bloom Lessons from SARS. Science. 2003;300:701.
49. NS Deodhar , VL Yemul , K. Banerjee Plague that never was: a review of the alleged plague outbreaks in India in 1994. J Public Health Policy. 1998;19:184–199.
50. DP. Fidler Emerging trends in international law concerning global infectious disease control. Emerg Infect Dis. 2003;9:285–290.
51. U Schuklenk , KM. Gartland Confronting an influenza pandemic: ethical and scientific issues. Biochem Soc Trans. 2006;34 (Pt 6):1151–1154.
52. D. Butler Disease surveillance needs a revolution. Nature. 2006;440:6–7.
53. C Beyrer , V Suwanvanichkij , LC Mullany , et alResponding to AIDS, tuberculosis, malaria, and emerging infectious diseases in Burma: dilemmas of policy and practice. PLoS Med. 2006;3:e393.
54. H. Koh Why do nations obey international law? Yale Law J. 1997;106:2599–2659.
55. DP. Fidler Globalization, international law, and emerging infectious diseases. Emerg Infect Dis. 1996;2:77–84.
56. JH. Tanne Tuberculosis case exposes flaws in international public health systems. BMJ. 2007;334:1187.